Psychopharmacology
Psychopharmacology
Psychopharmacology
Definitions
Antidepressants
Indications
- Treatment of dysthymic disorder.
- Major depression with melancholia or psychotic
symptoms.
- Depression associated with organic disease, alcoholism,
schizophrenia, or mental retardation;
- Depressive phase of bipolar disorder; and depression
accompanied by anxiety.
Antidepressants
Action
- These drugs ultimately work to increase the concentration
of norepinephrine, serotonin, and/or dopamine in the body
- This is accomplished in the brain by blocking the reuptake
of these neurotransmitters by the neurons (tricyclics,
selective serotonin reuptake inhibitors, and others).
- It also occurs when an enzyme, monoamine oxidase
(MAO), that is known to inactivate norepinephrine,
serotonin, and dopamine, is inhibited at various sites in the
nervous system.
Antidepressant Medications
Antidepressant Medications
Antidepressant Medications
Interactions (Tricyclics):
- Hyperpyretic crisis, hypertensive crisis, severe seizures,
and tachycardia may occur when used with MAOIs.
- Use of these drugs may decrease therapeutic response to
some antihypertensives (clonidine, guanethidine).
Antidepressant Medications
Interactions (MAOIs):
- Hypertensive crisis may occur with concurrent use of
amphetamines, methyldopa, levodopa, dopamine,
epinephrine, norepinephrine, reserpine, vasoconstrictors,
or ingestion of tyramine-containing foods.
Antidepressant Medications
Diagnosis:
- Risk for suicide related to depressed mood.
- Risk for injury related to side effects of sedation, lowered
seizure threshold, orthostatic hypotension, priapism,
photosensitivity, arrhythmias, hypertensive crisis, or
serotonin syndrome.
- Social isolation related to depressed mood.
- Constipation related to side effects of the medication
Antidepressant Medications
planning/Implementation
Antidepressant Medications
planning/Implementation
- Nausea:
* Medication may be taken with food to minimize GI
distress.
- Discontinuation syndrome
* All classes of antidepressants have varying potentials to
cause discontinuation syndromes.
* All antidepressant medication should be tapered gradually
to prevent withdrawal symptoms.
Antidepressant Medications
planning/Implementation
- Constipation:
* Order foods high in fiber; increase fluid intake if not
contraindicated; and encourage the client to increase physical
exercise, if possible.
Antidepressant Medications
planning/Implementation
- Urinary retention
* Instruct the client to report hesitancy or inability to urinate.
* Monitor intake and output.
* Try various methods to stimulate urination, such as running water in
the bathroom or pouring water over the perineal area.
- Orthostatic hypotension
* Instruct the client to rise slowly from a lying or sitting position.
* Monitor blood pressure (lying and standing) frequently, and
document and report significant changes.
* Avoid long hot showers or tub baths.
Antidepressant Medications
planning/Implementation
- Reduction of seizure threshold:
* Observe clients with history of seizures closely.
* Institute seizure precautions as specified in hospital procedure
manual.
* Bupropion (Wellbutrin) should be administered in doses of no more
than 150 mg and should be given at least 6 hours apart. Bupropion has
been associated with a relatively high incidence of seizure activity in
anorexic and cachectic clients.
- Tachycardia; arrhythmias
* Carefully monitor blood pressure and pulse rate and rhythm, and
report any significant change to the physician.
Antidepressant Medications
planning/Implementation
- Photosensitivity:
* Ensure that client wears a protective sunblock lotion,
clothing, and sunglasses while outdoors.
- Weight gain:
* Provide instructions for reduced-calorie diet.
* Encourage increased level of activity, if appropriate.
Antidepressant Medications
planning/Implementation
Antidepressant Medications
planning/Implementation
- Weight loss (may occur early in therapy)
* Ensure that client is provided with caloric intake sufficient to
maintain desired weight.
* Caution should be taken in prescribing these drugs for anorectic
clients.
* Weigh client daily or every other day, at the same time, and on the
same scale, if possible.
*After prolonged use, some clients may gain weight on SSRIs
- Sexual dysfunction:
* Men may report abnormal ejaculation or impotence.
* Women may experience delay or loss of orgasm.
* If side effect becomes intolerable, a switch to another antidepressant may
be necessary.
Antidepressant Medications
planning/Implementation
Most commonly occur with MAOIs:
- Hypertensive crisis
* Hypertensive crisis occurs if the individual consumes foods
containing tyramine while receiving MAOI therapy .
* Symptoms of hypertensive crisis include severe occipital headache,
palpitnuchal rigidity, fever, sweating, marked increase in blood
pressure, chest pain, and coma.
* Treatment of hypertensive crisis: discontinue drug immediately;
monitor vital signs; administer short-acting antihypertensive
medication, as ordered by physician; use external cooling measures
to control hyperpyrexia.
Mood-Stabilizing Agents
For
Nursing diagnosis
Risk for injury related to manic hyperactivity.
Risk for self-directed or other-directed violence
related to unresolved anger turned inward on the self
or outward on the environment.
Risk for injury related to lithium toxicity.
Risk for activity intolerance related to side effects of
drowsiness and dizziness.
Lithium Toxicity
The margin between the therapeutic and toxic levels of
lithium carbonate is very narrow. The usual ranges of
therapeutic serum concentrations are:
- For acute mania: 1.0 to 1.5 mEq/L
- For maintenance: 0.6 to 1.2 mEq/l
Serum lithium levels should be monitored once or twice a
week after initial treatment until dosage and serum levels
are stable, then monthly during maintenance therapy.
Blood samples should be drawn 12 hours after the last
dose.
Lithium Toxicity
Symptoms of lithium toxicity begin to appear at blood levels
greater than 1.5 mEq/L and are dosage determinate.
Symptoms include:
- At serum levels of 1.5 to 2.0 mEq/L: Blurred vision,
ataxia, tinnitus, persistent nausea and vomiting, severe diarrhea.
- At serum levels of 2.0 to 3.5 mEq/L: Excessive output of dilute
urine, increasing tremors, muscularirritability, psychomotor
retardation, mental confusion, giddiness.
- At serum levels above 3.5 mEq/L: Impaired consciousness,
nystagmus, seizures, coma, oliguria/ anuria, arrhythmias,
Antipsychotic Agents
Antipsychotic Agents
- Action
The exact mechanism of action is not known. These drugs
are thought to work by blocking postsynaptic dopamine
receptors in the basal ganglia, hypothalamus, limbic
system, brainstem, and medulla.
Newer medications may exert antipsychotic properties by
blocking action on receptors specific to dopamine,
serotonin, and other neurotransmitters
Diagnosis